Riskpilot← Back to searchSign inGet full accessJC Konsultläkare AB
ABActiveOrg 5590291331Klåvavägen 72General medical practice activities · NACE 8621Est. 20151 employees
Revenue 2025
SEK 2,2M
+7% vs 2024
EBITDA margin
50.8%
-41% vs 2024
Equity ratio
84.2%
Financial strength
Net profit 2025
SEK 1,1M
-49% vs 2024
| Revenue | SEK 2,2M | +7% |
| EBITDA | SEK 1,1M | -41% |
| Net profit | SEK 1,1M | -49% |
| Total assets | SEK 3,9M | +18% |
| Equity | SEK 3,3M | +27% |
| Employees | 1 | — |
Legal name
JC Konsultläkare AB
Org number
5590291331
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 oktober 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet inom allmän- och specialistläkarverksamhet inom företagshälsovård samt företagsledning. Äga, förvalta samt handel med fastigheter och värdepapper och därmed förenlig verksamhet.
Address
Klåvavägen 72
Email
jaana.cottell@outlock.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 962 | 2 217 | 1 913 | 2 078 | 2 229 |
| Staff expenses | — | −1 338 | −1 255 | −100 | −1 009 |
| EBITDA | 803 | 817 | 582 | 1 929 | 1 132 |
| Depreciation & amort. | −6 | — | — | — | −62 |
| EBIT | 797 | 817 | 582 | 1 929 | 1 070 |
| Net financials | — | −1 | 0 | 143 | −15 |
| Profit before tax | 796 | 962 | 713 | 2 312 | 1 335 |
| Tax | −197 | −228 | −176 | −233 | −280 |
| Net profit | 599 | 734 | 536 | 2 079 | 1 055 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 727 | 4 327 | 3 040 | 3 270 | 3 867 |
| Equity | 1 806 | 2 390 | 926 | 2 561 | 3 255 |
| Long-term debt | 0 | — | — | — | 335 |
| Short-term debt | 297 | 339 | 526 | 429 | 277 |
| Total debt | 297 | 339 | 526 | 429 | 612 |
EBITDA margin
50.8%
This company
15.8%
Market median
+222% vs market
20212025
Equity ratio
84.2%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
32.4%
This company
18.4%
Market median
+76% vs market
20212025
Net profit margin
47.3%
This company
8.1%
Market median
+484% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JC Konsultläkare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mitra Arjana Javadzadeh | Deputy Board Member | 0 companies |
| Jaana Anneli Cottell | Board of Directors | 0 companies |
| Richard Cottell | Deputy Board Member | 0 companies |